World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on October 1, 2026

Oct. 1, 2026

Phillips Edison & Company Announces $377.5 Million Expansion of Joint Venture with Northwestern Mutual

Indeterminate GlobeNewswire

Oct. 1, 2026

Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair

Indeterminate GlobeNewswire

Oct. 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

White Paper Says Gyms Aren't Built for Women; Carbon Performance Says Its Gyms Are Designed for Everyone

Indeterminate EIN Presswire

Oct. 1, 2026

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029

Indeterminate GlobeNewswire

Oct. 1, 2026

Sagimet Biosciences Announces Closing of Underwritten Offering of Series A Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire

Oct. 1, 2026

Integrass Completes Acquisitions of ClearCadence and StarTech Consulting

Indeterminate EIN Presswire

Oct. 1, 2026

Rally House Opening South Greenfield Store as Ninth Wisconsin Store

Indeterminate GlobeNewswire

Oct. 1, 2026

NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer

Indeterminate GlobeNewswire

Oct. 1, 2026

NANOBIOTIX annonce la nomination d’Arnd Christ au poste de directeur financier

Indeterminate GlobeNewswire

Oct. 1, 2026

ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering

Indeterminate GlobeNewswire

Oct. 1, 2026

Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation

Indeterminate GlobeNewswire

Oct. 1, 2026

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

Indeterminate GlobeNewswire

Oct. 1, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 1, 2026

Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026

Indeterminate GlobeNewswire

Oct. 1, 2026

Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel

Indeterminate GlobeNewswire

Oct. 1, 2026

Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader, at the 2026 International Congress of Parkinson’s Disease and Movement Disorders®

Indeterminate GlobeNewswire